# Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

> **NCT05601583** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 14 (actual)

## Conditions studied

- Type 2 Diabetes
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** Continuous Glucose Monitor (CGM)

## Key facts

- **NCT ID:** NCT05601583
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-19
- **Primary completion:** 2023-08-29
- **Final completion:** 2027-08-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05601583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05601583, "Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05601583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*